Recent studies suggest that reductions in circulating endothelial progenitor cells (EPCs) may contribute to the development of atherosclerosis. However, whether reduced circulating EPCs contribute to cerebrovascular disease remains undefined. We tested the hypothesis that reduced circulating EPCs was associated with an increased burden of carotid atherosclerosis. 
Recent studies suggest that reductions in circulating endothelial progenitor cells (EPCs) may contribute to the development of atherosclerosis. However, whether reduced circulating EPCs contribute to cerebrovascular disease remains undefined. We tested the hypothesis that reduced circulating EPCs was associated with an increased burden of carotid atherosclerosis. The level of circulating CD34 þ /KDR þ EPCs and the extent of carotid atherosclerosis were determined in 30 patients with a history of atherothrombotic ischaemic stroke and 30 age-and sex-matched controls (mean age: 6372 years; 63% men). Stroke patients, compared with controls, had significantly higher carotid mean maximum intima-media thickness (mmIMT) (1.0870.05 versus 0.9070.02 mm, P ¼ 0.002), prevalence of carotid plaque (60.0 versus 23.3%, P ¼ 0.004) and a lower number of circulating CD34 þ /KDR þ EPCs (235.7745.5 versus 400.4756.8 cells/ll, P ¼ 0.027). The circulating
CD34
þ /KDR þ EPC count correlated negatively with carotid mmIMT (r ¼ À0.50, Po0.001), and was an independent risk factor for increased carotid mmIMT41 mm (odds ratio (OR): 7.71; 95% confidence interval (CI): 1.62-36.74, P ¼ 0.010) and the presence of carotid plaque (OR: 7.04; 95% CI: 1.95-25.43, P ¼ 0.003). Furthermore, stroke patients with low (o25th percentile of controls) as compared to those with normal CD34 þ /KDR þ EPC count had a significantly greater carotid mmIMT (1.217 Introduction A balance between endothelial damage and repair plays a critical role in maintaining the integrity of the endothelium. Recent experimental studies have suggested that circulating endothelial progenitor cells (EPCs) originating from the bone marrow contribute to ongoing endothelial repair.
1,2 Impairment in mobilization or depletion of circulating EPCs may lead to endothelial dysfunction and progression of atherosclerosis. Indeed, clinical studies have demonstrated that the number of circulating EPCs inversely correlates with risk factors for atherosclerosis and endothelial dysfunction. 3 Furthermore, high circulating levels of EPCs, characterized by combined expression of CD34 and kinase insert domain receptor (KDR; CD34 þ /KDR þ ), are associated with reduced cardiovascular events, suggesting a protective effect of EPCs on progression of atherosclerotic diseases. 4, 5 Recent studies have also shown that the circulating CD34 þ cells are significantly reduced in patients with stroke as compared with controls. 6 However, it remains unclear whether the reduced level of circulating EPCs contribute to the occurrence of cerebrovascular disease. Among multiple cardiovascular risk factors, hypertension is a major determinant for carotid atherosclerosis and stroke. In this study, we sought to investigate the relationship between the number of circulating EPCs and hypertension with the burden of carotid atherosclerosis.
Materials and methods

Patients
Thirty patients with a prior history of atherothrombotic ischaemic stroke follow-up in our outpatient clinic were investigated. Cerebral infarction was confirmed by computerized axial tomography or magnetic resonance imaging of the brain. Patients with haemorrhagic stroke, suspected cardioembolic stroke, stroke owing to other causes, recent acute myocardial ischaemic events or surgery within the last 3 months, history of malignancy, and the presence of atrial fibrillation were excluded. Thirty age-and sex-matched subjects who had no history of cardiovascular or cerebrovascular diseases were enrolled as control. The study was approved by the institutional review board. All subjects provided informed consent.
Demographic and laboratory evaluations
Baseline demographic data, cardiovascular risk factors and cardiovascular medications were documented in all subjects. Cardiovascular risk factors, including tobacco smoking, diabetes mellitus, hypercholesterolemia, hypertension, body mass index (BMI) and family history of cardiovascular diseases in first-degree relatives younger than 55 years of age were assessed. Hypertension was defined as either resting systolic or diastolic blood pressure X140/90 mm Hg at two different times or on medications. Diabetes mellitus was defined as a serum fasting glucose of X6.7 mmol/l or on medications. Hypercholesterolemia was defined as a fasting total serum cholesterol level of X4.9 mmol/l or on medications. BMI was calculated as weight in kilograms divided by square of height in metres. Smoking status was recorded as either smoker (past and current) or non-smoker. Fasting venous blood samples were obtained to determine serum glucose and lipid levels, and circulating EPC counts. Blood sampling and carotid ultrasound were performed at a median of 24 (4-130) months after the stroke in the study group. Both the blood sampling and carotid ultrasound were carried out on the same day.
Carotid ultrasound
Carotid atherosclerosis was evaluated through a standard B-mode ultrasound examination with the use of a 7.5 MHz linear array transducer and a highresolution ultrasound system (Agilent Sonos 5500, Philips, USA) by a single experienced operator, who was blinded to the identity of study subjects. All subjects were examined in a supine position and the intima-media thickness (IMT) of the carotid arteries were measured as described previously. 7, 8 Briefly, carotid IMT was determined by measuring the distance between the lumen-intima and mediaadventia border of the vascular wall using electronic calipers. Each ultrasonic scan was performed in the anterior, lateral and posterior projections of the right and left carotid arteries. Three IMT measurements were made on the near and far wall of the left and right common carotid arteries, carotid bifurcation and internal carotid arteries. The mean maximum IMT (mmIMT) was calculated by averaging the values of maximum IMT measured from 12 preselected segments in the carotid arteries. Plaque thickness was incorporated in IMT measurement. Carotid plaque was defined as a regional intimal thickening of 41.4 mm in height or double the adjacent IMT height. 9 Inter-observer correlation between repeated IMT measurements from 13 subjects was 0.97 (Po0.001) for mmIMT and 0.91 (Po0.001) for maximum IMT.
Flow cytometry
Fluorescence-activated cell analysis was performed to determine the number of EPCs. Briefly, 100 ml of peripheral blood was incubated with a phycoerythrin-conjugated monoclonal antibody against human KDR (Sigma, St Louis, MO, USA), followed by a fluorescein isothiocyanate (FITC)-conjugated CD34 antibody (Beckman Coulter, Fullerton, CA, USA). FITC-labelled anti-human CD45 antibody was used for differential gating during flow analysis. FITC-labelled IgG1a (Beckman Coulter) and phycoerythrin-labelled IgG2b (Becton Dickinson, Franklin Lakes, NJ, USA) served as the isotypic control for colour compensation. Analysis was performed with an automated fluorescence-activated cell counter (Elite, Beckman Coulter) in which 1 000 000 events were counted. The absolute cell counts of all the measured components per 1 000 000 events in the lymphocyte gate were calculated.
Statistical analysis
To have at least 80% power to detect a 25% difference in EPC between the two groups with a 5% maximum false-positive error rate, we would need a minimum of 27 patients from each group. Continuous variables were presented as mean7 standard error of mean (s.e.m.). Categorical data were presented as frequencies and percentages. Statistical comparisons were performed with Student's t-test or Pearson's r-test, as appropriate. Correlations between variables were evaluated by calculating the Spearman's correlation coefficient. A univariate binary logistic regression model was used to identify the risk factors associated with carotid atherosclerosis. Variables with significant associations (Po0.05) were then entered into a multivariate binary logistic regression model to identify the independent predictors for carotid atherosclerosis. Calculations were performed with use of the SPSS software (version 13.0). A P-value of o0.05 was considered statistically significant.
Results
Baseline characteristics
As shown in Table 1 , there were no significant differences in gender, age, BMI, hyperlipidemia, smoking and family history of cardiovascular diseases between stroke patients and controls. However, patients with stroke had a significantly higher prevalence of hypertension and diabetes compared with controls (Table 1) .
Circulating EPC and carotid atherosclerosis
As determined by flow cytometry for the presence of circulating EPCs, CD34
þ /KDR þ cells were found to be significantly decreased in stroke patients compared with controls ( Figure 1, 235 .7745.5 versus 400.4756.8 cells/ml, P ¼ 0.027). The mmIMT was significantly greater and the prevalence of carotid plaque significantly higher in stroke patients compared with controls (Table 1 ). In fact, circulating CD34 þ /KDR þ EPCs were correlated inversely with the carotid mmIMT (r ¼ À0.50, Po0.001, Figure 2 Figure 3 ) and a significantly higher prevalence of carotid plaque (87.5% versus 28.6%; P ¼ 0.001, Figure 4 ) compared to those with a normal CD34 þ /KDR þ EPC count.
Hypertension and carotid atherosclerosis
Patients with hypertension had significantly higher incidence of stroke and diabetes, greater mmIMT and lower circulating CD34 þ /KDR þ EPC count compared with those without hypertension (Table 3) . However, there were no significant differences in age, gender, prevalence of other cardiovascular risk factors and carotid plaque between patients with or without hypertension ( Table 3 ).
Predictors for carotid atherosclerosis
As shown in Table 4 , univariate analysis revealed than age, hypertension, smoking, diabetes and a low 
Discussion
In this study, we have showed that circulating EPCs were negatively associated with carotid IMT. Furthermore, stroke patients with low EPC levels showed a greater degree of carotid atherosclerosis. Furthermore, the number of circulating EPC was an independent predictor for both carotid IMT and plaque formation. Taken together, these observations Figure 4 Patients with low EPC counts showed a significantly higher prevalence of carotid plaque.
Endothelial progenitor cells and atherosclerosis K-K Lau et al of the conventional cardiovascular risk factors, including hypertension predicted both the carotid IMT and plaque formation as a low CD34
þ /KDR þ cell count. These observations validated CD34 þ / KDR þ cells as a reflection of EPCs that might contribute to vascular endothelial repair. Interestingly, despite similar risk factors and cardiovascular medications, stroke patients with reduced circulating EPCs had a more severe carotid atherosclerosis, as reflected by a greater carotid IMT and a three-time higher prevalence of carotid plaque. This finding provided further evidence to suggest that circulating EPCs might impact on the progression of carotid atherosclerosis. However, despite the promising results from our study, larger prospective studies to investigate on this possible causation would be required to confirm these findings. Furthermore, univariate analysis revealed that diabetes was also a predictor for both carotid IMT and plaque formation. The small number of subjects with diabetes in this study might result in underestimation of the importance of diabetes during multivariate analysis. Therefore, future studies are required to clarify the role of diabetes and reduced EPC on the burden of carotid atherosclerosis.
In conclusion, the findings from this study suggest a link between the level of circulating EPCs and carotid atherosclerosis. Measurement of circulating EPC count may provide a novel marker for the burden of carotid atherosclerosis independent to conventional cardiovascular risk factors, including hypertension.
What is known about this topic: K Circulating EPCs originating from the bone marrow contribute to ongoing endothelial repair.
1,2
K Recent studies have also shown that the circulating EPCs are significantly reduced in patients with stroke as compared with controls. 6 What this study adds: K Our observations suggested that reduced circulating EPC contributed to the progression of carotid atherosclerosis in patients with stroke, independent to the conventional cardiovascular risk factors, including hypertension. 
